Gilead, Janssen Settle HIV Treatment Suits With Lupin, Apotex
By Andrea Keckley
Gilead Sciences Inc. and Johnson & Johnson's Janssen unit settled their patent suits against Lupin and Apotex over generic versions of HIV treatments, according to filings in Delaware federal court on Wednesday.